California’s stem cell research agency has said it intends to bring stem cell based treatments and therapies to fruition faster.
The California Institute for Regenerative Medicine (CIRM) launched what it calls its CIRM 2.0 initiative on 23 October. The institute said it would spend $24 million on building three clinics and promised a 120-day turnaround for clinical-trial funding.
According to C Randal Mills, president and chief executive of CIRM, the changed funding process will reduce the time from application to full funding from as long as 2 years to just 4 months. Initially the process will only be available to research projects ready to begin clinical trials, he said, but it will eventually be open to all applicants.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.